Drreddys Laboratories | RDY - Ebit


Drreddys Laboratories reported INR16.37B in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Aurora Cannabis CAD -44.75M 27.14M Sep/2025
Bayer EUR 1.11B 1.51B Dec/2025
Canopy Growth CAD -14.3M 17.19M Sep/2025
Cipla INR 9.77B 6.21B Dec/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Drreddys Laboratories INR 16.37B 3.5B Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Hikma Pharmaceutical USD 348M 31M Dec/2025
Lonza CHF 673M 54M Jun/2025
Novartis USD -9.19B 13.87B Jun/2025
Pacira USD 3.19M 9.96M Dec/2025
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 82.49M 2.82M Dec/2025
Richter Gedeon HUF 63.58B 6.08B Sep/2025
Sun Pharmaceuticals INR 40.62B 6.95B Dec/2025
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025